A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type.
Phase of Trial: Phase III
Latest Information Update: 29 Nov 2013
At a glance
- Drugs Aripiprazole (Primary)
- Indications Psychotic disorders
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 02 Mar 2012 Actual patients number changed from 208 to 232 as reported by ClinicalTrials.gov.
- 23 Sep 2011 New trial record